Changeflow GovPing Healthcare & Life Sciences Octapeptide Patent Filed for Antibacterial
Routine Rule Added Final

Octapeptide Patent Filed for Antibacterial

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

USPTO published patent application US20260109735A1 for an immunomodulatory octapeptide with broad-spectrum antibacterial activity, filed September 2, 2025 under Application No. 19317121. The application names Feiyun Yang, Jinxiu Huang, and Xiuliang Ding as inventors and covers the peptide's preparation method, purity testing, and applications in anti-bacterial and immunomodulation fields for animal husbandry. CPC classifications include C07K 7/64, A61P 31/04, C12P 21/02, G01N 33/6851, and A61K 38/00.

“The disclosure provides an immunomodulatory octapeptide, and this small peptide molecule has a unique structure, higher broad-spectrum antibacterial activity, stronger pathogenic bacteria inhibition and high purity, can maintain stability of its structure and antibacterial activity in artificial gastric juice, with no obvious hemolytic activity, and has high application value in animal husbandry.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

USPTO classification C07K covers peptides: short amino-acid chains that form the backbone of antibodies, hormones, vaccines, and increasingly a wider class of therapeutic modalities. Every newly published application in C07K lands in this feed, around 175 a month. Applications publish 18 months after filing, so this feed reveals what antibody engineering groups, vaccine developers, and plant biotech researchers were working on in the prior year and a half. Watch this if you compete in biologics, file freedom-to-operate analyses on antibody drug candidates, scout acquisition targets in vaccine platforms, or track protein-based agricultural biotech filings.

What changed

USPTO published patent application US20260109735A1 for an octapeptide composition, its method of preparation, and applications in anti-bacterial and immunomodulation. The application claims an immunomodulatory octapeptide characterized by unique structure, broad-spectrum antibacterial activity, pathogenic bacteria inhibition, stability in artificial gastric juice, and absence of hemolytic activity. The filing date is September 2, 2025, with Application No. 19317121.\n\nAffected parties include pharmaceutical companies, biotechnology researchers, and drug manufacturers working with peptide-based antibacterial agents. Competitors developing similar immunomodulatory peptides or antimicrobial compounds should review the application to assess potential patent landscape implications and freedom-to-operate considerations.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

OCTAPEPTIDE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN ANTI-BACTERIUM AND IMMUNOMODULATION

Application US20260109735A1 Kind: A1 Apr 23, 2026

Inventors

Feiyun Yang, Jinxiu Huang, Xiuliang Ding

Abstract

The disclosure provides an immunomodulatory octapeptide, and this small peptide molecule has a unique structure, higher broad-spectrum antibacterial activity, stronger pathogenic bacteria inhibition and high purity, can maintain stability of its structure and antibacterial activity in artificial gastric juice, with no obvious hemolytic activity, and has high application value in animal husbandry. The disclosure provides a preparation method and a purity test method of this immunomodulatory octapeptide.

CPC Classifications

C07K 7/64 A61P 31/04 C12P 21/02 G01N 33/6851 A61K 38/00

Filing Date

2025-09-02

Application No.

19317121

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260109735A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing Biotechnology research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!